Mackenzie Financial »

Taysha Gene Therapies shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2024-12-31 $17k 10k 1.73
2024-09-30 $20k 10k 2.01

More positions owned by Mackenzie Financial

Royal Bank of Canada Common Stock (RY)
Rbc Cad (RY)
Microsoft Corp Common Stock (MSFT)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (Principal) (SPY)
Apple Common Stock (AAPL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
SPDR S&P 500 ETF Trust Etp (SPY)
Stantec (STN)
Toronto-Dominion Bank/The Common Stock (TD)
Toronto Dominion Bk Ont Com New (TD)
Amazon.com Common Stock (AMZN)
Amazon (AMZN)
Thomson Reuters Corp. (TRI)

View all positions for Mackenzie Financial

Top funds holding Taysha Gene Therapies

venBio Select Advisor
Morgan Stanley
FMR
BlackRock
RA Capital Management
Octagon Capital Advisors
Vanguard Group
Rtw Investments
State Street Corporation
Adage Capital Partners GP
Siren
Baker Bros. Advisors
Tybourne Capital Management
Geode Capital Management
VR Adviser

View all funds holding Taysha Gene Therapies